Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Sun Communities, Inc., a real estate investment trust specializing in manufactured housing and RV communities, announced a third quarter 2026 distribution of $1.12 per common share payable on October 15, 2026. The announcement demonstrates the company’s continued commitment to returning value to shareholders from its extensive portfolio of properti…
Mission Produce announced its fiscal Q3 2026 financial results, showing 26% revenue growth to $450 million driven by a 38% increase in avocado volume, including contributions from the recent Calavo acquisition. Despite reporting a net loss due to acquisition-related costs, adjusted net income and EBITDA remained strong. The company reaffirmed its f…
BridgeBio Oncology Therapeutics reported encouraging clinical data for its KRASG12C inhibitor BBO-8520, showing high response rates in both monotherapy and combination with pembrolizumab in non-small cell lung cancer (NSCLC) patients. The company is prioritizing BBO-8520 combinations in 2L+ KRASG12C inhibitor-experienced NSCLC and advancing BBO-118…
Carlsmed, Inc., a Nasdaq-listed medical technology company specializing in AI-enabled personalized spine surgery solutions, has promoted Jeff Bertolini to Chief Operating Officer. Bertolini's history with the company includes leadership roles focused on operational excellence and advanced manufacturing technologies. The management believes his expe…
Intuitive Surgical announced a comprehensive meta-analysis demonstrating that da Vinci robotic-assisted surgery offers statistically significant benefits compared to laparoscopic and open surgeries across 13 common benign conditions. The study analyzed data from over 14 million procedures internationally, highlighting improved perioperative outcome…
Journey Medical Corporation, a Nasdaq-listed pharmaceutical company specializing in FDA-approved dermatology prescription products, announced CEO Claude Maraoui's participation in two investor conferences in September 2026. The company will present at the Lake Street Capital Markets 10th Annual Best Ideas Growth Conference and the H.C. Wainwright 2…
InnovAge Holding Corp. announced its financial results for the fiscal year ended June 30, 2026, highlighting a strong turnaround with nearly $990 million in revenues, a marginal net loss of $0.7 million compared to a $35.3 million loss the prior year, and increased Adjusted EBITDA of $94.6 million. The company also issued optimistic financial guida…
Protara Therapeutics, a clinical-stage biotech company specializing in transformative therapies for cancer and rare diseases, announced management will present at the H.C. Wainwright 28th Annual Global Investment Conference. The presentation will cover their clinical pipeline including TARA-002, focused on non-muscle invasive bladder cancer and lym…
ServiceTitan named Rikus Pretorius, former Senior Vice President of Worldwide Sales, as its new Chief Revenue Officer effective from the start of the fiscal fourth quarter. Pretorius succeeds Ross Biestman, who is stepping back from day-to-day operations after nearly a decade as CRO but will remain an advisor through fiscal 2027 to ensure a smooth …
ServiceTitan, a leading software platform for contractors and trades, announced its fiscal second quarter 2027 financial results highlighting 21% year-over-year revenue growth to $292.8 million and generating over $50 million in non-GAAP free cash flow. The company emphasized accelerating adoption of its AI-enhanced Agentic Operating System, with o…
Barnes & Noble Education (NYSE: BNED) reported fiscal 2027 first quarter results with a 29% improvement in net income (loss) and 19% improvement in adjusted EBITDA year-over-year. Revenue rose slightly to $290.6 million, driven by growth in the BNC First Day® Complete program, which will reach an estimated 1.43 million students this fall — a 26% in…
CAMP4 Therapeutics announced a virtual Analyst Day on September 28, 2026, to present details on CMP-002, a novel antisense oligonucleotide therapeutic designed to treat SYNGAP1-related disorder, a rare genetic condition with no approved disease-modifying therapies. The company plans to initiate a Phase 1/2 clinical trial of CMP-002 in Q4 2026 and w…
Korsana Biosciences finalized its merger with Cyclerion Therapeutics and completed a $380 million private financing, positioning the company with approximately $475 million in cash to fund operations into 2029. The combined company will begin trading on Nasdaq under ticker KRSA starting September 9, 2026. Korsana’s lead program, KRSA-028, a next-ge…
Braveheart Bio, a clinical-stage biopharmaceutical company focusing on hypertrophic cardiomyopathy (HCM) treatments, reported successful initiation of the global Phase 3 LIONHEART-HCM trial for BHB-1893 targeting obstructive HCM (oHCM). Following a promising Phase 2 trial demonstrating significant improvements in cardiac biomarkers and function, th…
Sandisk (SNDK) has moved from commodity memory vendor to a datacenter-focused NAND powerhouse. With fiscal 2026 revenue of $20.25B, free cash flow of $11.494B, and gross margins at 84.6%, the stock merits a constructive long trade. I recommend buying near $1,740 with a $1,600 stop and a primary target of $2,200 over a multi-horizon plan.
Ascendis Pharma A/S, a biopharmaceutical company focused on innovative TransCon technology, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026. The company highlights its commitment to developing best-in-class therapies addressing unmet medical needs.
Pyxis Oncology announced a live webcast to present updated clinical data from its Phase 1 study of micvotabart pelidotin (MICVO) as monotherapy in patients with second-line and beyond recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). The presentation will cover efficacy, safety, dosing details, and next clinical development st…
Keros Therapeutics, a clinical-stage biopharmaceutical company, announced that its Board approved a $5 million share repurchase program funded by a $20 million milestone payment from Takeda Pharmaceuticals after dosing the first patient in the ELRiSE MDS trial. The repurchase authorization allows management to buy back shares depending on market co…
Assembly Biosciences has exercised its option to share 40% of U.S. development costs and profits in collaboration with Gilead Sciences for its investigational helicase-primase inhibitor program targeting recurrent genital herpes. The decision follows review of Gilead’s development plan and advances the GS-1179 candidate toward a Phase 2 clinical tr…
Northern Technologies International Corporation (NTIC) has appointed Gautam Ramdas as President and CEO, succeeding G. Patrick Lynch who becomes Chairman of the Board. Brian Haglund is promoted to Chief Operating Officer. These leadership changes are part of NTIC's succession planning designed to capitalize on growth opportunities, especially in co…
CoinShares PLC announced it will release its financial results for the first half of 2026 on September 14, 2026, before market open. The company will hold a live earnings conference call and Q&A session the same day to discuss results, focusing on its digital asset management and institutional platform performance.
Nike shareholders on Tuesday declined a resolution that would have required the company to disclose more granular information about its climate objectives and the strategies intended to achieve emissions reductions. The vote leaves intact management control over sustainability disclosures even as the company navigates financial pressures, political…
Absci reported a positive Phase 1 readout for ABS-201 in androgenetic alopecia (AGA) and enters a run of operational catalysts while the stock trades at ~$8.91 with a market cap near $1.53B. The balance sheet shows meaningful cash per share versus price, short interest remains elevated, and technicals are neutral. This trade idea outlines a tactica…
Truist Financial Corp. has added three senior bankers to Truist Securities, appointing leaders for insurance brokers and services, healthcare advisory, and FIG investment grade debt capital markets. The hires, drawn from Guy Carpenter, Jefferies, Duff & Phelps, UBS, Moelis and Citigroup, form part of the bank's push to expand its advisory business …
Cognition AI Inc. announced a $2 billion Series E round that places the artificial intelligence software company at a $48 billion valuation. The financing was led by new investors Andreessen Horowitz and Accel alongside a broad syndicate of existing backers. The startup reported run-rate revenue climbing from $492 million to nearly $900 million sin…
